Elevance Health (ELV) Competitors $348.92 -1.33 (-0.38%) Closing price 07/3/2025 03:55 PM EasternExtended Trading$350.15 +1.23 (+0.35%) As of 07/3/2025 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ELV vs. CNC, MOH, UNH, CI, HUM, DHR, CVS, COR, NTRA, and LHShould you be buying Elevance Health stock or one of its competitors? The main competitors of Elevance Health include Centene (CNC), Molina Healthcare (MOH), UnitedHealth Group (UNH), Cigna Group (CI), Humana (HUM), Danaher (DHR), CVS Health (CVS), Cencora (COR), Natera (NTRA), and Labcorp (LH). These companies are all part of the "medical" sector. Elevance Health vs. Its Competitors Centene Molina Healthcare UnitedHealth Group Cigna Group Humana Danaher CVS Health Cencora Natera Labcorp Centene (NYSE:CNC) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, earnings, dividends, profitability, valuation and risk. Does the media prefer CNC or ELV? In the previous week, Centene had 21 more articles in the media than Elevance Health. MarketBeat recorded 85 mentions for Centene and 64 mentions for Elevance Health. Elevance Health's average media sentiment score of 0.81 beat Centene's score of 0.04 indicating that Elevance Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Centene 16 Very Positive mention(s) 11 Positive mention(s) 23 Neutral mention(s) 19 Negative mention(s) 8 Very Negative mention(s) Neutral Elevance Health 27 Very Positive mention(s) 4 Positive mention(s) 30 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals have more ownership in CNC or ELV? 93.6% of Centene shares are held by institutional investors. Comparatively, 89.2% of Elevance Health shares are held by institutional investors. 0.4% of Centene shares are held by insiders. Comparatively, 0.3% of Elevance Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has more volatility & risk, CNC or ELV? Centene has a beta of 0.44, meaning that its stock price is 56% less volatile than the S&P 500. Comparatively, Elevance Health has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500. Which has higher earnings and valuation, CNC or ELV? Elevance Health has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCentene$163.07B0.10$3.31B$6.714.96Elevance Health$177.01B0.45$5.98B$25.6313.61 Do analysts rate CNC or ELV? Centene presently has a consensus price target of $68.87, indicating a potential upside of 106.96%. Elevance Health has a consensus price target of $498.87, indicating a potential upside of 42.97%. Given Centene's higher possible upside, equities research analysts clearly believe Centene is more favorable than Elevance Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Centene 0 Sell rating(s) 10 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.41Elevance Health 0 Sell rating(s) 4 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 2.75 Is CNC or ELV more profitable? Elevance Health has a net margin of 3.23% compared to Centene's net margin of 2.04%. Elevance Health's return on equity of 18.61% beat Centene's return on equity.Company Net Margins Return on Equity Return on Assets Centene2.04% 14.56% 4.75% Elevance Health 3.23%18.61%6.80% SummaryElevance Health beats Centene on 12 of the 16 factors compared between the two stocks. Get Elevance Health News Delivered to You Automatically Sign up to receive the latest news and ratings for ELV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ELV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ELV vs. The Competition Export to ExcelMetricElevance HealthMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$78.59B$7.31B$5.53B$20.72BDividend Yield1.97%2.78%5.24%3.72%P/E Ratio13.6127.9427.5228.09Price / Sales0.4532.39421.0238.30Price / Cash8.8822.0136.8922.53Price / Book1.956.698.044.58Net Income$5.98B$233.06M$3.18B$986.06M7 Day Performance-8.48%3.33%2.90%2.79%1 Month Performance-9.28%3.72%3.70%5.46%1 Year Performance-34.20%37.40%36.15%15.06% Elevance Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ELVElevance Health4.9727 of 5 stars$348.92-0.4%$498.87+43.0%-34.2%$78.59B$177.01B13.61104,200CNCCentene4.9826 of 5 stars$54.09+0.2%$77.71+43.7%-50.2%$26.92B$163.07B8.0674,300Trending NewsAnalyst ForecastOptions VolumeAnalyst RevisionMOHMolina Healthcare4.9901 of 5 stars$297.58+0.2%$364.21+22.4%-19.2%$16.13B$40.65B14.3718,000UNHUnitedHealth Group4.9977 of 5 stars$311.13+0.7%$415.57+33.6%-37.0%$282.24B$400.28B13.03400,000Positive NewsOptions VolumeCICigna Group4.9742 of 5 stars$329.15+0.9%$380.39+15.6%-1.8%$87.93B$254.47B18.2371,300Positive NewsHUMHumana4.649 of 5 stars$243.55+0.7%$280.76+15.3%-34.2%$29.39B$120.26B17.2267,100Trending NewsAnalyst RevisionDHRDanaher4.8847 of 5 stars$197.41-0.7%$248.61+25.9%-15.4%$141.28B$23.82B38.3363,000Positive NewsCVSCVS Health4.9909 of 5 stars$68.75+0.4%$75.38+9.6%+18.8%$86.97B$372.81B16.41300,000CORCencora4.6792 of 5 stars$298.62-0.3%$306.33+2.6%+33.1%$57.88B$293.96B34.6442,000Positive NewsAnalyst RevisionNTRANatera2.1651 of 5 stars$168.98+0.6%$184.63+9.3%+44.7%$23.07B$1.70B-114.953,020Positive NewsInsider TradeLHLabcorp4.3996 of 5 stars$262.25+0.6%$276.08+5.3%+28.5%$21.95B$13.01B30.3275,500Positive NewsInsider Trade Related Companies and Tools Related Companies Centene Alternatives Molina Healthcare Alternatives UnitedHealth Group Alternatives Cigna Group Alternatives Humana Alternatives Danaher Alternatives CVS Health Alternatives Cencora Alternatives Natera Alternatives Labcorp Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ELV) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elevance Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elevance Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.